Protein Identified That May Aid Aggressive Breast Cancer Brain Metastasis

Researchers at Wake Forest University School of Medicine have discovered a protein that appears to facilitate the spread of an aggressive subtype of breast cancer to the brain and may help the tumor evade the immune system. The study, published in a peer‑reviewed journal, identified the protein as a key mediator in the metastatic cascade, enabling cancer cells to cross the blood‑brain barrier and establish secondary tumors within neural tissue.

The team used a combination of molecular profiling and in‑vivo models to demonstrate that the protein enhances cellular adhesion and signaling pathways that suppress immune surveillance. By blocking the protein’s activity, the researchers were able to reduce brain metastasis in animal models, suggesting a potential therapeutic target for patients with triple‑negative breast cancer, the most aggressive form. The findings also provide insight into the mechanisms by which tumors manipulate host defenses to support their growth in distant organs.

If further validated in clinical trials, targeting this protein could lead to new treatments that prevent or limit brain metastases in breast cancer patients. The research underscores the importance of understanding tumor–host interactions and offers a promising avenue for improving outcomes in a disease that currently has limited options for preventing central nervous system involvement.